Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Binh Dinh Pharmaceutical And Medical Equipment JSC's Enterprise Value for the quarter that ended in Mar. 2026 was ₫4,583,439 Mil.
Binh Dinh Pharmaceutical And Medical Equipment JSC's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫348,012 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC EV-to-EBIT Related Terms
Binh Dinh Pharmaceutical And Medical Equipment JSC EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC EV-to-EBIT Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Binh Dinh Pharmaceutical And Medical Equipment JSC EV-to-EBIT vs Drug Manufacturers Industry
Binh Dinh Pharmaceutical And Medical Equipment JSC's current Enterprise Value is ₫4,413,372 Mil.
Binh Dinh Pharmaceutical And Medical Equipment JSC's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫348,012 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a EV-to-EBIT of 12.68 as of Jul. 20, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. This is near median its historical median of 12.38. Over the past decade, Binh Dinh Pharmaceutical And Medical Equipment JSC's EV-to-EBIT has ranged from 8.27 to 24.59. According to the industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #277 out of 689 companies in the Drug Manufacturers industry, placing it in the top 40.2%.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's EV-to-EBIT too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current EV-to-EBIT of 12.68 is near median its 10-year median of 12.38. Over the past 10 years, this metric has ranged from a low of 8.27 to a high of 24.59. The Drug Manufacturers industry median EV-to-EBIT is 16.00. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 12.68 is 20.8% below this industry median. Based on the distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #277 out of 689 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's EV-to-EBIT compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #277 out of 689 companies for EV-to-EBIT. This puts Binh Dinh Pharmaceutical And Medical Equipment JSC in the upper half of its industry. The industry median EV-to-EBIT is 16.00. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 12.68 is 20.8% below this benchmark. Historically, Binh Dinh Pharmaceutical And Medical Equipment JSC's own EV-to-EBIT has ranged from 8.27 to 24.59 over the past decade. While the company's 10-year median is 12.38 vs. the industry median of 16.00, Binh Dinh Pharmaceutical And Medical Equipment JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 16.00, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current EV-to-EBIT of 12.68 is 20.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 16.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current EV-to-EBIT is 12.68, which is near median its own 10-year median of 12.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,514.28, compared to a current price of ₫49,900.00 — trading 5% below its estimated fair value. The current EV-to-EBIT is 12.68, which is near median its 10-year median of 12.38 and 20.8% below the Drug Manufacturers industry median of 16.00. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current EV-to-EBIT is 12.68 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be undervalued.
The current stock price of ₫49,900.00 is trading 5% below its estimated GF Value™ of ₫52,514.28.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
EV-to-EBIT: 12.68 (near median its 10-year median of 12.38)
GF Value™: ₫52,514.28 vs. price of ₫49,900.00 (5% below fair value)
Industry Position: 20.8% below the Drug Manufacturers median (#277 of 689)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score
Get the complete analysis for STC:DBD
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
